Search

Your search keyword '"A. Fortier"' showing total 803 results
Start Over Author "A. Fortier" Publisher elsevier b.v.
803 results on '"A. Fortier"'

2. Posttraumatic survivor guilt is associated with white matter microstructure alterations

Author

Rojczyk, Philine, Seitz-Holland, Johanna, Heller, Carina, Marcolini, Sofia, Marshall, Amy D., Sydnor, Valerie J., Kaufmann, Elisabeth, Jung, Leonard B., Bonke, Elena M., Berger, Luisa, Umminger, Lisa F., Wiegand, Tim L.T., Cho, Kang Ik K., Rathi, Yogesh, Bouix, Sylvain, Pasternak, Ofer, Hinds, Sidney R., Fortier, Catherine B., Salat, David, Milberg, William P., Shenton, Martha E., and Koerte, Inga K.

Published
2024
Full Text
View/download PDF

12. Optimization of pharmacotherapies for ambulatory patients with heart failure and reduced ejection fraction is associated with improved outcomes

Author

Jarjour, Marilyne, Leclerc, Jacinthe, Bouabdallaoui, Nadia, Ahnadi, Charaf, Brouillette, Denis, de Denus, Simon, Fortier, Annik, Garceau, Patrick, Giraldeau, Geneviève, Lepage, Serge, Liszkowski, Mark, O'Meara, Eileen, Parent, Marie-Claude, Racine, Normand, Tremblay-Gravel, Maxime, White, Michel, Rouleau, Jean-Lucien, and Ducharme, Anique

Published
2023
Full Text
View/download PDF

17. Pre-transplant Anemia as a Marker of Short-term Outcomes in Lung Transplant Recipients.

Author

Trindade, Anil J., Fortier, Avery K., Tucker, William D., Martel, Abigail K., Gannon, Whitney D., and Bacchetta, Matthew

Subjects
*RED blood cell transfusion, *GRAFT rejection, *LENGTH of stay in hospitals, *TREATMENT effectiveness, *LUNG transplantation
Abstract

Anemia is a risk factor for increased morbidity and mortality in multiple medical conditions, yet the impact of pretransplant anemia in patients with advanced lung disease on post-transplant outcomes remains under-explored. We sought to determine whether pretransplant anemia serves as a marker of altered inflammation in the host and associates with short-term outcomes following lung transplantation. We performed a single-center, retrospective analysis of 238 lung transplant recipients. We assessed for risk factors of pretransplant anemia and identified associations with short-term post-transplant outcomes. Pretransplant anemia was associated with increased intraoperative transfusion of packed red blood cells and a trend towards increased index hospital length of stay and 1-year mortality. Conversely, pretransplant anemia was associated with a decreased incidence of acute cellular rejection. These preliminary data suggest that anemia may be a biomarker of altered inflammation in the host recipient and influences post-transplant outcomes. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

38. Audiometric evaluation and diagnosis of conductive hearing loss.

Author

Morse-Fortier, Charlotte, Doney, Elizabeth, Fallon, Keelin, and Remenschneider, Aaron

Abstract

Definitive diagnosis of conductive hearing loss requires a comprehensive audiological evaluation by a skilled audiologist. Threshold testing is performed with both air and bone conduction stimuli and frequently necessitates masking strategies. The fundamental aspects of bone conduction audiometry will be reviewed. Patients with bilateral conductive or mixed hearing loss need advanced strategies, such as the Rainville estimation method to acquire ear specific thresholds. 1 One hallmark of conductive hearing loss is preserved word recognition due to intact cochlear function. Immittance testing is another important component to comprehensive audiometry and can provide important information about the site of the conductive lesion. This article will review the fundamental aspects of the audiologic assessment of conductive hearing loss and touch on areas of recent research advances, including the assessment of high frequency conductive hearing loss using specialized bone conduction hardware. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

44. Common characteristics of shoulder injury related to vaccine administration following COVID-19 vaccination: a comprehensive systematic review.

Author

Fortier, Luc M., Smith, Kira L., Ina, Jason G., Sinkler, Margaret A., Calcei, Jacob G., Salata, Michael J., Gillespie, Robert, and Voos, James E.

Abstract

The pathogenesis of shoulder injury related to vaccine administration (SIRVA) is incompletely understood, but it is postulated to be an immune-mediated inflammatory response to a vaccine antigen, leading to shoulder pain and dysfunction. The purpose of this investigation is to systematically review the literature related to SIRVA specifically after the COVID-19 vaccination by describing the diagnostic and clinical characteristics, diagnoses associated with SIRVA, and incidence between vaccine types. A systematic review was performed to identify level I to IV studies and case descriptions of shoulder pain occurring after COVID-19 vaccination. To confirm that no studies were missing from the systematic review, references of studies from the initial search were scanned for additional relevant studies. A total of 22 studies, comprised of 81 patients, were identified meeting the inclusion/exclusion criteria. Reports were most commonly published from countries in Asia (53.1%; n = 43/81). The most commonly described vaccines were Oxford-AstraZeneca at 37.0% (n = 30/81) and Pfizer-BioNTech at 33.3% (n = 27/81). Symptoms occurred most commonly after at least 72 hours of administration (30.9%, n = 25/81). One hundred percent of patients (n = 81/81) described pain as an associated symptom and 90.1% of patients (n = 73/81) described multiple symptoms. The diagnostic modalities utilized to identify a specific pathology consisted of magnetic resonance imaging (55.6%; n = 45/81), ultrasound (28.4; n = 23/81), radiograph (25.9%; n = 21/81), and computed tomography (4.9%; 4/81). Nearly a third of patients (32.1%; n = 26/81) were diagnosed with bursitis, while 22 (27.2%) were diagnosed with adhesive capsulitis, 17 (21.0%) with either rotator cuff tear or tendinopathy, and 14 (17.3%) with polymyalgia rheumatica or polymyalgia rheumatica-like syndrome. The 2 most common treatment options were physical therapy (34.6%; n = 28/81) and nonsteroidal anti-inflammatory medications (33.3%; 27/81). The majority of SIRVA cases (52.1%; n = 38/73) completely resolved within a few weeks to months. Despite the limited quality and lack of large-scale studies, it is important for providers to recognize SIRVA as a potential risk factor as the number of patients receiving COVID-19 vaccinations and boosters continues to rise. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results